Changes in glycosphingolipid composition during differentiation of human embryonic stem cells to ectodermal or endodermal lineages

Stem Cells

Volumn 29, Issue 12, 2011, Pages 1995-2004

  Liang, Yuh Jin ^a   Yang, Bei Chia ^b   Chen, Jin Mei ^c   Lin, Yu Hsing ^d   Huang, Chia Lin ^b   Cheng, Yuan Yuan ^d   Hsu, Chi Yen ^a   Khoo, Kay Hooi ^c   Shen, Chia Ning ^b   Yu, John ^a,b  

^a INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Differentiation; Glycosphingolipids; Glycosyltransferases; Human embryonic stem cells; Matrix assisted laser desorption ionization mass spectrometry; Surface markers

Indexed keywords

CERAMIDE; EMBRYONIC ANTIGEN 3; EMBRYONIC ANTIGEN 4; FETAL ANTIGEN; GANGLIOSIDE GD3; GLYCOSPHINGOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRUCTURE; CONTROLLED STUDY; ECTODERM; EMBRYONIC STEM CELL; ENDODERM; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPOGENESIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEURAL STEM CELL; TANDEM MASS SPECTROMETRY;

CELL DIFFERENTIATION; CELL LINEAGE; ECTODERM; EMBRYONIC STEM CELLS; ENDODERM; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GANGLIOSIDES; GLOBOSIDES; GLYCOSPHINGOLIPIDS; GLYCOSYLTRANSFERASES; HUMANS; NEURAL STEM CELLS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 81855168289     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.750     Document Type: Article

References (43)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147. (Pubitemid 28516247)
2. Reubinoff BE, Pera MF, Fong CY et al. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404. (Pubitemid 30217526)
3. Pera MF, Reubinoff B, Trounson A. Human embryonic stem cells. J Cell Sci 2000;113:5-10. (Pubitemid 30066328)
4. Davila JC, Cezar GG, Thiede M et al. Use and application of stem cells in toxicology. Toxicol Sci 2004;79:214-223. (Pubitemid 38786878)
5. Hakomori S. Structure and function of glycosphingolipids and sphingolipids: Recollections and future trends. Biochim Biophys Acta 2008;1780:325-346.
6. Hakomori S. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett 2010;584:1901-1906.
7. Yu RK, Macala LJ, Taki T, Weinfield HM, Yu FS. Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J Neurochem 1988;50:1825-1829.
8. Yu RK. Development regulation of ganglioside metabolism. Prog Brain Res 1994;101:31-44. (Pubitemid 24084736)
9. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 1978;75:5565-5569. (Pubitemid 9084529)
10. Kannagi R, Cochran NA, Ishigami F et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 1983;2:2355-2361.
11. Kannagi R, Levery SB, Ishigami F et al. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem 1983;258:8934-8942. (Pubitemid 13026724)
12. Shevinsky LH, Knowles BB, Damjanov I et al. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 1982;30:697-705. (Pubitemid 13204659)
13. Kerr MA, Stocks SC. The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion. Histochem J 1992;24:811-826.
14. Jungalwala FB. Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system - A review. Neurochem Res 1994;19:945-957. (Pubitemid 24243329)
15. Prinetti A, Loberto N, Chigorno V et al. Glycosphingolipid behaviour in complex membranes. Biochim Biophys Acta 2009;1788:184-193.
16. Sonnino S, Prinetti A. Sphingolipids and membrane environments for caveolin. FEBS Lett 2009;583:597-606.
17. Guan F, Handa K, Hakomori SI. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci USA 2009;106:7461-7466.
18. Guan F, Schaffer L, Handa K, Hakomori SI. Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-beta. FASEB J 2010;24:4889-4903.
19. Ullmann U, In't Veld P, Gilles C et al. Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod 2007;13:21-32. (Pubitemid 44942721)
20. Eastham AM, Spencer H, Soncin F et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 2007;67:11254-11262. (Pubitemid 350248551)
21. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development 2005;132:3151-3161. (Pubitemid 41167144)
22. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005;233:706-720. (Pubitemid 40853448)
23. Ciruna B, Rossant J. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell 2001;1:37-49. (Pubitemid 33586067)
24. Liang YJ, Kuo HH, Lin CH et al. Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation. Proc Natl Acad Sci USA 2010;107:22564-22569.
25. Chang WW, Lee CH, Lee P et al. Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proc Natl Acad Sci USA 2008;105:11667-11672.
26. Pankratz MT, Li XJ, Lavaute TM et al. Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 2007;25:1511-1520. (Pubitemid 47106020)
27. Cho MS, Lee YE, Kim JY et al. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 2008;10:3392-3397.
28. Cai J, Zhao Y, Liu Y et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007;45:1229-1239. (Pubitemid 46775786)
29. Van Dyken SJ, Green RS, Marth JD. Structural and mechanistic features of protein O glycosylation linked to CD8+ T-cell apoptosis. Mol Cell Biol 2007;27:1096-1111. (Pubitemid 46174570)
30. Hakomori S, Ishizuka I. Glycolipids: Animal. Encyclopedia of Life Sciences. Chichester, UK: Wiley, 2006.
31. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B And O: Their changes associated with human cancer. Biochim Biophys Acta 1999;1473:247-266.
32. Miyagi T, Wada T, Iwamatsu A et al. Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J Biol Chem 1999;274:5004-5011.
33. Kakugawa Y, Wada T, Yamaguchi K et al. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA 2002;99:10718-10723.
34. Prinetti A, Aureli M, Illuzzi G et al. GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells. Glycobiology 2009;20:62-77.
35. Ono M, Handa K, Sonnino S et al. GM3 ganglioside inhibits CD9- facilitated haptotactic cell motility: Coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 2001;40:6414-6421. (Pubitemid 32472731)
36. Kawakami Y, Kawakami K, Steelant WF et al. Tetraspanin CD9 is a "proteolipid," and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. J Biol Chem 2002;277:34349-34358.
37. Mitsuzuka K, Handa K, Satoh M et al. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem 2005;280:35545-35553. (Pubitemid 41532746)
38. Todeschini AR, Dos Santos JN, Handa K et al. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem 2007;282:8123-8133. (Pubitemid 47093583)
39. Toledo MS, Suzuki E, Handa K et al. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor. J Biol Chem 2005;280:16227-16234. (Pubitemid 40616749)
40. Warburg O. On the origin of cancer cells. Science 1956;123:309-314.
41. Hakomori S. Cell adhesion/recognition, signal transduction through glycosphingolipid microdomain. Glycoconj J 2000;17:143-151. (Pubitemid 32055900)
42. Ngamukote S, Yanagisawa M, Ariga T et al. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J Neurochem 2007;103:2327-2341. (Pubitemid 350173557)
43. Jung JU, Ko K, Lee DH et al. The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells. Exp Mol Med 2009;41:935-945.